{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:14:51Z","timestamp":1793128491845,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.prostaglandins.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T22:48:09Z","timestamp":1491086889000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis"],"prefix":"10.1016","volume":"130","author":[{"given":"Michael J.","family":"Pulkoski-Gross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim D.","family":"Uys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Alexa","family":"Orr-Gandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Coant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka B.","family":"Bialkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdzislaw M.","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Bielawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyelle M.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf A.","family":"Hannun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M.","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Snider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nature reviews. Molecular cell biology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0010","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0015","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential role for sphingosine kinases in neural and vascular development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lyphoid organs is deendent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2007.11.002","article-title":"Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages","volume":"85","author":"Hammad","year":"2008","journal-title":"Prostaglandins & other lipid mediators"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-5793(00)01510-6","article-title":"Functional characterization of human sphingosine kinase-1","volume":"473","author":"Nava","year":"2000","journal-title":"FEBS letters"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0035","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.4049\/jimmunol.1000644","article-title":"Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis","volume":"185","author":"Baker","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0040","first-page":"S0091","article-title":"A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma","volume":"12","author":"Price","year":"2017","journal-title":"J. Allergy Clin. Immunol"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1096\/fj.08-118109","article-title":"A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis","volume":"23","author":"Snider","year":"2009","journal-title":"Faseb J."},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0050","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1096\/fj.02-1038com","article-title":"The sphingosine kinase 1\/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha","volume":"17","author":"Pettus","year":"2003","journal-title":"Faseb J."},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cellsig.2004.12.005","article-title":"Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators","volume":"17","author":"Billich","year":"2005","journal-title":"Cellular signalling"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.489443","article-title":"Sphingosine Kinase 1 (SK1) regulates Tumor Necrosis Factor (TNF)-mediated RANTES Induction Through p38 MAPK but Independently of NF-kappaB Activation","author":"Adada","year":"2013","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1096\/fj.05-4331fje","article-title":"Sphingosine kinase 1 is up-regulated in colon carcinogenesis","volume":"20","author":"Kawamori","year":"2006","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0070","doi-asserted-by":"crossref","first-page":"e113998","DOI":"10.1371\/journal.pone.0113998","article-title":"Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease","volume":"9","author":"Snider","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0075","article-title":"Sphingosine-1-phosphate metabolism: A structural perspective","volume":"1\u201316","author":"Pulkoski-Gross","year":"2015","journal-title":"Critical reviews in biochemistry and molecular biology1"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbalip.2012.07.002","article-title":"Targeting the sphingosine kinase\/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors","volume":"1831","author":"Orr Gandy","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0085","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2013.06.002","article-title":"Optimizing anti-TNF treatments in inflammatory bowel disease","volume":"13","author":"Ben-Horin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0095","series-title":"Sphingo-guanidines and their use as inhibitors of sphingosine kinase. WO 2010078247 A1","author":"Szulc","year":"2010"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymeth.2006.05.004","article-title":"Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry","volume":"39","author":"Bielawski","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0076-6879(07)34012-3","article-title":"Combination of C(17) sphingoid base homologues and mass spectrometry analysis as a new approach to study sphingolipid metabolism","volume":"434","author":"Spassieva","year":"2007","journal-title":"Methods in enzymology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ab.2003.11.018","article-title":"Fluorescence-based assay of sphingosine kinases","volume":"326","author":"Billich","year":"2004","journal-title":"Analytical biochemistry"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prostaglandins.2012.08.003","article-title":"Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease","volume":"99","author":"Snider","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0120","first-page":"1372","article-title":"Processing of gene expression data generated by quantitative real-time RT-PCR","volume":"32","author":"Muller","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0125","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1021\/jm701207m","article-title":"Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities","volume":"50","author":"Ohara","year":"2007","journal-title":"Journal of medicinal chemistry"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0130","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0135","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2013-02-486217","article-title":"Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation","volume":"121","author":"De Filippo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0140","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.cellsig.2016.06.007","article-title":"Recent advances in the development of sphingosine kinase inhibitors","volume":"28","author":"Pitman","year":"2016","journal-title":"Cellular signalling"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0145","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.3178","article-title":"A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties","author":"Pitman","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0150","doi-asserted-by":"crossref","first-page":"e68328","DOI":"10.1371\/journal.pone.0068328","article-title":"Sphingosine kinase activity is not required for tumor cell viability","volume":"8","author":"Rex","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"Schnute","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0160","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1016\/j.febslet.2005.08.055","article-title":"Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells","volume":"579","author":"Sarkar","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0165","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1096\/fj.05-4412fje","article-title":"Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis","volume":"20","author":"Taha","year":"2006","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0170","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10620-007-0133-6","article-title":"Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase","volume":"53","author":"Maines","year":"2008","journal-title":"Digestive diseases and sciences"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10787-010-0032-x","article-title":"Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease","volume":"18","author":"Maines","year":"2010","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"333","author":"French","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0185","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1016\/j.bmc.2016.05.047","article-title":"Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice","volume":"24","author":"Xi","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1096\/fj.08-118109","article-title":"A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis","volume":"23","author":"Snider","year":"2009","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0195","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2011-06-358614","article-title":"S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release","volume":"119","author":"Golan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0200","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0205","article-title":"Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient","author":"Yanagida","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0210","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.it.2015.10.005","article-title":"Exit Strategies: S1P Signaling and T Cell Migration","volume":"36","author":"Baeyens","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0215","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1096\/fj.06-7433com","article-title":"Erythrocytes store and release sphingosine 1-phosphate in blood","volume":"21","author":"Hanel","year":"2007","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.prostaglandins.2017.03.006_bib0220","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.bbalip.2014.06.012","article-title":"The role of sphingosine-1-phosphate in endothelial barrier function","volume":"1841","author":"Wilkerson","year":"2014","journal-title":"Biochim Biophys Acta"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316301587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316301587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T10:21:42Z","timestamp":1568974902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882316301587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":44,"alternative-id":["S1098882316301587"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.03.006","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}